Nicholas Uth is an accomplished inventor based in Washington, DC. He has made significant contributions to the field of bioprocess control, particularly through his innovative use of Raman spectroscopy. With a total of 2 patents to his name, Uth's work is paving the way for advancements in automated cell culture monitoring.

Latest Patents

One of Uth's latest patents focuses on the automated control of cell culture using Raman spectroscopy. This invention provides a method for monitoring and controlling bioprocesses by generating generic calibration models that are independent of cell lines. The technology utilizes inline Raman probes to track changes in various parameters, including glucose, lactate, glutamate, ammonium, viable cell concentration (VCC), total cell concentration (TCC), and product concentration. The calibration models were developed using two different CHOK1SV GS-KO™ cell lines that produce distinct monoclonal antibodies (mAbs). Uth's predictive models have shown minor prediction errors when measuring changes in glucose, lactate, ammonium, VCC, and TCC, demonstrating minimal dependence on the cell line used. This innovation allows for the application of spectroscopic Process Analytical Technology (PAT) techniques in clinical manufacturing environments, where processes are typically executed once or twice based on a common platform.

Career Highlights

Nicholas Uth is currently employed at Lonza Inc., where he continues to develop groundbreaking technologies in bioprocessing. His work has been instrumental in enhancing the efficiency and reliability of biomanufacturing processes.

Collaborations

Uth collaborates with talented professionals in his field, including Thaddaeus Webster and Brian Hadley. Their combined expertise contributes to the advancement of innovative solutions in bioprocess control.

Conclusion

Nicholas Uth's contributions to the field of bioprocess control through his patents and collaborations highlight his role as a leading inventor in the industry. His work not only enhances the efficiency of biomanufacturing but also sets the stage for future innovations in the field.